TAKEDA PHARMA A/S — Credit Rating and Financial Key Figures

TAKEDA PHARMA A/S (CVR number: 16406899) is a company from VALLENSBÆK. The company reported a net sales of 1102.4 mDKK in 2024, demonstrating a decline of -1.5 % compared to the previous year. The operating profit percentage was at 1.6 % (EBIT: 17.2 mDKK), while net earnings were 12.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 3.8 %, which can be considered weak and Return on Equity (ROE) was 3.4 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 63.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. TAKEDA PHARMA A/S's liquidity measured by quick ratio was 0.8 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.